Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling

Kutlu G. Elpek, Esma S. Yolcu, Deanna D H Franke, Chantale Lacelle, Rich Henry Schabowsky, Haval Shirwan

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Naturally occurring CD4+CD25+FoxP3+ T regulatory (Treg) cells require three distinct signals transduced via TCR, CD28, and IL-2R for their development and maintenance. These requirements served as the basis for several recently developed ex vivo expansion protocols that relied on the use of solid support-bound Abs to CD3 and CD28 in the presence of high dose IL-2. We report in this study that Treg cells up-regulate the expression of inducible costimulatory receptor 4-1BB in response to IL-2, and stimulation using this receptor via a novel form of 4-1BB ligand (4-1BBL) fused to a modified form of core streptavidin (SA-4-1BBL) was effective in expanding these cells up to 110-fold within 3 wk. Expanded cells up-regulated CD25, 4-1BB, and membranous TGF-β, suppressed T cell proliferation, and prevented the rejection of allogeneic islets upon adoptive transfer into graft recipients. Importantly, SA-4-1BBL rendered CD4+CD25- T effector cells refractive to suppression by Treg cells. This dual function of signaling via 4-1BB, vis-à-vis Treg cell expansion and licensing T effector cells resistant to Treg cell suppression, as well as the up-regulation of 4-1BB by IL-2 may serve as important regulatory mechanisms for immune homeostasis following antigenic challenge. Stimulation using a soluble form of SA-4-1BBL represents a novel approach to expand Treg cells with potential therapeutic applications in autoimmunity and transplantation.

Original languageEnglish (US)
Pages (from-to)7295-7304
Number of pages10
JournalJournal of Immunology
Volume179
Issue number11
StatePublished - Dec 1 2007

Fingerprint

4-1BB Ligand
Regulatory T-Lymphocytes
Interleukin-4
Interleukin-2
CD137 Antigens
Up-Regulation
Streptavidin
Adoptive Transfer
Licensure
Autoimmunity
Homeostasis
Transplantation
Maintenance
Cell Proliferation
T-Lymphocytes
Transplants

ASJC Scopus subject areas

  • Immunology

Cite this

Elpek, K. G., Yolcu, E. S., Franke, D. D. H., Lacelle, C., Schabowsky, R. H., & Shirwan, H. (2007). Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. Journal of Immunology, 179(11), 7295-7304.

Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. / Elpek, Kutlu G.; Yolcu, Esma S.; Franke, Deanna D H; Lacelle, Chantale; Schabowsky, Rich Henry; Shirwan, Haval.

In: Journal of Immunology, Vol. 179, No. 11, 01.12.2007, p. 7295-7304.

Research output: Contribution to journalArticle

Elpek, KG, Yolcu, ES, Franke, DDH, Lacelle, C, Schabowsky, RH & Shirwan, H 2007, 'Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling', Journal of Immunology, vol. 179, no. 11, pp. 7295-7304.
Elpek, Kutlu G. ; Yolcu, Esma S. ; Franke, Deanna D H ; Lacelle, Chantale ; Schabowsky, Rich Henry ; Shirwan, Haval. / Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. In: Journal of Immunology. 2007 ; Vol. 179, No. 11. pp. 7295-7304.
@article{48e37b2cad9940009c0687e76cd8b9ca,
title = "Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling",
abstract = "Naturally occurring CD4+CD25+FoxP3+ T regulatory (Treg) cells require three distinct signals transduced via TCR, CD28, and IL-2R for their development and maintenance. These requirements served as the basis for several recently developed ex vivo expansion protocols that relied on the use of solid support-bound Abs to CD3 and CD28 in the presence of high dose IL-2. We report in this study that Treg cells up-regulate the expression of inducible costimulatory receptor 4-1BB in response to IL-2, and stimulation using this receptor via a novel form of 4-1BB ligand (4-1BBL) fused to a modified form of core streptavidin (SA-4-1BBL) was effective in expanding these cells up to 110-fold within 3 wk. Expanded cells up-regulated CD25, 4-1BB, and membranous TGF-β, suppressed T cell proliferation, and prevented the rejection of allogeneic islets upon adoptive transfer into graft recipients. Importantly, SA-4-1BBL rendered CD4+CD25- T effector cells refractive to suppression by Treg cells. This dual function of signaling via 4-1BB, vis-{\`a}-vis Treg cell expansion and licensing T effector cells resistant to Treg cell suppression, as well as the up-regulation of 4-1BB by IL-2 may serve as important regulatory mechanisms for immune homeostasis following antigenic challenge. Stimulation using a soluble form of SA-4-1BBL represents a novel approach to expand Treg cells with potential therapeutic applications in autoimmunity and transplantation.",
author = "Elpek, {Kutlu G.} and Yolcu, {Esma S.} and Franke, {Deanna D H} and Chantale Lacelle and Schabowsky, {Rich Henry} and Haval Shirwan",
year = "2007",
month = "12",
day = "1",
language = "English (US)",
volume = "179",
pages = "7295--7304",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling

AU - Elpek, Kutlu G.

AU - Yolcu, Esma S.

AU - Franke, Deanna D H

AU - Lacelle, Chantale

AU - Schabowsky, Rich Henry

AU - Shirwan, Haval

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Naturally occurring CD4+CD25+FoxP3+ T regulatory (Treg) cells require three distinct signals transduced via TCR, CD28, and IL-2R for their development and maintenance. These requirements served as the basis for several recently developed ex vivo expansion protocols that relied on the use of solid support-bound Abs to CD3 and CD28 in the presence of high dose IL-2. We report in this study that Treg cells up-regulate the expression of inducible costimulatory receptor 4-1BB in response to IL-2, and stimulation using this receptor via a novel form of 4-1BB ligand (4-1BBL) fused to a modified form of core streptavidin (SA-4-1BBL) was effective in expanding these cells up to 110-fold within 3 wk. Expanded cells up-regulated CD25, 4-1BB, and membranous TGF-β, suppressed T cell proliferation, and prevented the rejection of allogeneic islets upon adoptive transfer into graft recipients. Importantly, SA-4-1BBL rendered CD4+CD25- T effector cells refractive to suppression by Treg cells. This dual function of signaling via 4-1BB, vis-à-vis Treg cell expansion and licensing T effector cells resistant to Treg cell suppression, as well as the up-regulation of 4-1BB by IL-2 may serve as important regulatory mechanisms for immune homeostasis following antigenic challenge. Stimulation using a soluble form of SA-4-1BBL represents a novel approach to expand Treg cells with potential therapeutic applications in autoimmunity and transplantation.

AB - Naturally occurring CD4+CD25+FoxP3+ T regulatory (Treg) cells require three distinct signals transduced via TCR, CD28, and IL-2R for their development and maintenance. These requirements served as the basis for several recently developed ex vivo expansion protocols that relied on the use of solid support-bound Abs to CD3 and CD28 in the presence of high dose IL-2. We report in this study that Treg cells up-regulate the expression of inducible costimulatory receptor 4-1BB in response to IL-2, and stimulation using this receptor via a novel form of 4-1BB ligand (4-1BBL) fused to a modified form of core streptavidin (SA-4-1BBL) was effective in expanding these cells up to 110-fold within 3 wk. Expanded cells up-regulated CD25, 4-1BB, and membranous TGF-β, suppressed T cell proliferation, and prevented the rejection of allogeneic islets upon adoptive transfer into graft recipients. Importantly, SA-4-1BBL rendered CD4+CD25- T effector cells refractive to suppression by Treg cells. This dual function of signaling via 4-1BB, vis-à-vis Treg cell expansion and licensing T effector cells resistant to Treg cell suppression, as well as the up-regulation of 4-1BB by IL-2 may serve as important regulatory mechanisms for immune homeostasis following antigenic challenge. Stimulation using a soluble form of SA-4-1BBL represents a novel approach to expand Treg cells with potential therapeutic applications in autoimmunity and transplantation.

UR - http://www.scopus.com/inward/record.url?scp=38849108168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849108168&partnerID=8YFLogxK

M3 - Article

VL - 179

SP - 7295

EP - 7304

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -